Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)

Article Dentistry, Oral Surgery & Medicine

Oral manifestations accompanying and related to COVID-19: Overlooking the obvious

Gabriela Anaya-Saavedra

ORAL DISEASES (2022)

添加到收藏夹

Letter Dermatology

COVID-19: a possible trigger for oral lichen planus?

Patricia Burgos-Blasco et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

添加到收藏夹

Letter Dermatology

Lichen planus arising after COVID-19 vaccination

I. Hiltun et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Evaluation of the safety profile of COVID-19 vaccines: a rapid review

Qianhui Wu et al.

Summary: Meta-analysis of safety profiles of COVID-19 vaccines showed that different platforms of vaccines have different safety outcomes, with age groups of vaccine recipients also playing a role in safety profiles. Long-term population-level surveillance is needed to further define the safety profile of COVID-19 vaccines.

BMC MEDICINE (2021)

添加到收藏夹

Letter Dermatology

COVID-19 vaccination: possible short-term exacerbations of oral mucosal diseases

Roopali Kulkarni et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Letter Dermatology

New-onset cutaneous lichen planus triggered by COVID-19 vaccination

R. Merhy et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Galit Alter et al.

Summary: The Ad26.COV2.S vaccine has shown clinical efficacy against symptomatic COVID-19, including the B.1.351 variant, but there is uncertainty regarding its immunogenicity against SARS-CoV-2 variants. The study found that neutralizing antibody responses were reduced against the B.1.351 and P.1 variants, while non-neutralizing antibody responses and T cell responses were largely preserved against SARS-CoV-2 variants.

NATURE (2021)

添加到收藏夹

Article Dermatology

Cutaneous reactions to vaccinations

Adena E. Rosenblatt et al.

CLINICS IN DERMATOLOGY (2015)

添加到收藏夹

Review Dermatology

Oral lichen planus: an update on its pathogenesis

Patricia A. Nogueira et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)

添加到收藏夹

Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)

相关参考文献

导出引文

分享论文